• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力的流行病学、管理及患者需求:基于德尔菲法的意大利多利益相关方共识

Epidemiology, management and patient needs in myasthenia gravis: an Italian multistakeholder consensus based on Delphi methodology.

作者信息

Habetswallner Francesco, Iorio Raffaele, Annicchiarico Giuseppina, Limongelli Giuseppe, Uccheddu Maria Bonaria, Galeone Carlotta, Mariani Paolo, Mantegazza Renato

机构信息

Clinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy.

Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

BMJ Open. 2024 Dec 22;14(12):e086225. doi: 10.1136/bmjopen-2024-086225.

DOI:10.1136/bmjopen-2024-086225
PMID:39806659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11667248/
Abstract

OBJECTIVES

To provide comprehensive information on the burden of myasthenia gravis (MG) in Italy, including the unmet needs of patients and several other aspects related to the disease, based on skilled viewpoints of MG experts.

DESIGN

Iterative analysis conducted in accordance with the best practices of the Delphi method, including anonymity, controlled feedback, and statistical stability of consensus.

SETTING AND PARTICIPANTS

24 clinicians, 18 public health experts and 4 patient associations experts completed all the Delphi iterations between 18 April and 3 July 2023, for a total of 46 participants from several Italian Regions.

OUTCOME MEASURES

Five areas of investigation related to MG were examined: epidemiology in Italy and characteristics of disease; diagnostic issues and Italian patient journey; unmet needs during the acute and chronic phases of MG; quality of life; public health management of MG. Consensus in the Delphi iterations was defined by both the percentage level of agreement between panellists or the median value of the responses.

RESULTS

We reported a high level of agreement (ie, >66.7% of panellists) on the prevalence and incidence of disease in Italy and on several management issues. A strong impact of MG on the quality of life of patients also emerged. Cross-agreement was achieved among different subgroups of panellists (ie, clinicians, public health experts and patient associations representatives) for most items proposed.

CONCLUSIONS

This study provided guidance for educational and practical aspects of MG in Italy, highlighted disease severity and its role on patients' quality of life. A few gaps related to the handling of MG in Italy also emerged.

摘要

目的

基于重症肌无力(MG)专家的专业观点,提供有关意大利重症肌无力负担的全面信息,包括患者未满足的需求以及与该疾病相关的其他几个方面。

设计

按照德尔菲法的最佳实践进行迭代分析,包括匿名性、可控反馈和共识的统计稳定性。

背景与参与者

24名临床医生、18名公共卫生专家和4名患者协会专家在2023年4月18日至7月3日期间完成了所有德尔菲迭代,共有来自意大利多个地区的46名参与者。

观察指标

研究了与重症肌无力相关的五个调查领域:意大利的流行病学和疾病特征;诊断问题和意大利患者就医过程;重症肌无力急性和慢性阶段未满足的需求;生活质量;重症肌无力的公共卫生管理。德尔菲迭代中的共识由专家小组成员之间的一致百分比水平或回答的中位数定义。

结果

我们报告了在意大利疾病的患病率和发病率以及几个管理问题上达成了高度一致(即超过66.7%的专家小组成员)。重症肌无力对患者生活质量的强烈影响也显现出来。对于大多数提出的项目,在不同的专家小组成员亚组(即临床医生、公共卫生专家和患者协会代表)之间达成了交叉共识。

结论

本研究为意大利重症肌无力的教育和实践方面提供了指导,强调了疾病的严重性及其对患者生活质量的影响。在意大利重症肌无力的处理方面也出现了一些差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5044/11667248/e498c3ff81f0/bmjopen-14-12-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5044/11667248/f09cf2234c2e/bmjopen-14-12-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5044/11667248/a88d077afaca/bmjopen-14-12-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5044/11667248/e498c3ff81f0/bmjopen-14-12-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5044/11667248/f09cf2234c2e/bmjopen-14-12-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5044/11667248/a88d077afaca/bmjopen-14-12-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5044/11667248/e498c3ff81f0/bmjopen-14-12-g003.jpg

相似文献

1
Epidemiology, management and patient needs in myasthenia gravis: an Italian multistakeholder consensus based on Delphi methodology.重症肌无力的流行病学、管理及患者需求:基于德尔菲法的意大利多利益相关方共识
BMJ Open. 2024 Dec 22;14(12):e086225. doi: 10.1136/bmjopen-2024-086225.
2
Epidemiology, Characteristics of Disease, and Unmet Needs of Patients with Generalized Pustular Psoriasis: A Large Italian Delphi Consensus.泛发性脓疱型银屑病的流行病学、疾病特征和患者的未满足需求:一项大型意大利德尔菲共识。
Dermatology. 2024;240(3):414-424. doi: 10.1159/000538072. Epub 2024 Mar 18.
3
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus.酸性鞘磷脂酶缺乏症(ASMD):填补意大利未满足需求和患者就医过程中的知识空白——德尔菲共识
Intern Emerg Med. 2023 Apr;18(3):831-842. doi: 10.1007/s11739-023-03238-3. Epub 2023 Mar 7.
4
Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis.改善和规范全身性重症肌无力患者评估的专家共识建议。
Eur J Neurol. 2024 Jul;31(7):e16280. doi: 10.1111/ene.16280. Epub 2024 Mar 24.
5
Italian recommendations for the diagnosis and treatment of myasthenia gravis.意大利关于重症肌无力的诊断和治疗建议。
Neurol Sci. 2019 Jun;40(6):1111-1124. doi: 10.1007/s10072-019-03746-1. Epub 2019 Feb 18.
6
Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable data.迈向欧洲各国重症肌无力登记系统的协调统一:基于德尔菲改进法的可收集数据专家共识
Orphanet J Rare Dis. 2025 Mar 11;20(1):115. doi: 10.1186/s13023-024-03520-3.
7
Current challenges in focal epilepsy treatment: An Italian Delphi consensus.当前局灶性癫痫治疗的挑战:意大利德尔菲共识。
Epilepsy Behav. 2024 Jun;155:109796. doi: 10.1016/j.yebeh.2024.109796. Epub 2024 Apr 20.
8
Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: results of an Italian Delphi Panel.乳腺癌幸存者(BCS)的外阴阴道萎缩(VVA)仍然是一个未满足的医疗需求:意大利德尔菲小组的结果。
Support Care Cancer. 2020 Jun;28(6):2507-2512. doi: 10.1007/s00520-019-05272-4. Epub 2020 Jan 22.
9
Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy.用于骨关节炎的症状性慢作用药物(SYSADOA)的临床标准的适宜性。意大利专家间的德尔菲共识倡议。
Eur J Phys Rehabil Med. 2019 Oct;55(5):658-664. doi: 10.23736/S1973-9087.19.05633-8. Epub 2019 May 15.
10
Development of a supportive care framework for breast cancer survivor's unmet needs: A modified Delphi study.开发乳腺癌幸存者未满足需求的支持性护理框架:一项修正德尔菲研究。
J Clin Nurs. 2024 Apr;33(4):1376-1386. doi: 10.1111/jocn.16963. Epub 2024 Feb 14.

本文引用的文献

1
The impact of diagnosis delay on European patients with generalised myasthenia gravis.诊断延误对欧洲全身性重症肌无力患者的影响。
Ann Clin Transl Neurol. 2024 Sep;11(9):2254-2267. doi: 10.1002/acn3.52122. Epub 2024 Aug 1.
2
Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion.重症肌无力治疗的挑战和未满足的需求:意大利专家观点。
Neurol Sci. 2024 Dec;45(12):5671-5683. doi: 10.1007/s10072-024-07577-7. Epub 2024 Jul 5.
3
ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi.
ACCORD(准确共识报告文件):通过改良 Delphi 法制定的生物医学共识方法报告指南。
PLoS Med. 2024 Jan 23;21(1):e1004326. doi: 10.1371/journal.pmed.1004326. eCollection 2024 Jan.
4
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy.重新聚焦广义重症肌无力:患者负担、疾病特征和不断发展的治疗方法的作用。
Eur J Neurol. 2024 Jun;31(6):e16180. doi: 10.1111/ene.16180. Epub 2023 Dec 20.
5
People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies.与一般人群相比,患有重症肌无力的人健康相关生活质量较低,需要更多的医疗和护理帮助:两项观察性研究分析。
Adv Ther. 2023 Oct;40(10):4377-4394. doi: 10.1007/s12325-023-02604-z. Epub 2023 Jul 25.
6
Mental health in myasthenia gravis patients and its impact on caregiver burden.重症肌无力患者的心理健康及其对照顾者负担的影响。
Sci Rep. 2022 Nov 11;12(1):19275. doi: 10.1038/s41598-022-22078-3.
7
Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders.自身免疫性神经肌肉接头疾病的流行病学、诊断和生物标志物。
Lancet Neurol. 2022 Feb;21(2):176-188. doi: 10.1016/S1474-4422(21)00297-0.
8
Burden of disease in myasthenia gravis: taking the patient's perspective.重症肌无力的疾病负担:从患者角度出发。
J Neurol. 2022 Jun;269(6):3050-3063. doi: 10.1007/s00415-021-10891-1. Epub 2021 Nov 20.
9
Development of a Model Care Pathway for Myasthenia Gravis.重症肌无力模型护理路径的制定。
Int J Environ Res Public Health. 2021 Nov 4;18(21):11591. doi: 10.3390/ijerph182111591.
10
Myasthenia gravis: do not forget the patient perspective.重症肌无力:不要忘记患者的视角。
Neuromuscul Disord. 2021 Oct 8. doi: 10.1016/j.nmd.2021.07.396.